Cargando…

Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report

INTRODUCTION AND IMPORTANCE: Cancer of unknown primary site (CUP) is metastatic cancer without primary tumor found from comprehensive medical history, physical examination, and regular laboratory examination. Eighty percent of CUP include unfavorable groups with 3 to 6 months of median survival desp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yulian, Erwin Danil, Hwei, Lie Rebecca Yen, Tambun, Renaningtyas, Siswoyo, Alvita Dewi, Ham, Maria Fransisca, Suroyo, Indrati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961183/
https://www.ncbi.nlm.nih.gov/pubmed/35339815
http://dx.doi.org/10.1016/j.ijscr.2022.106954
_version_ 1784677543453917184
author Yulian, Erwin Danil
Hwei, Lie Rebecca Yen
Tambun, Renaningtyas
Siswoyo, Alvita Dewi
Ham, Maria Fransisca
Suroyo, Indrati
author_facet Yulian, Erwin Danil
Hwei, Lie Rebecca Yen
Tambun, Renaningtyas
Siswoyo, Alvita Dewi
Ham, Maria Fransisca
Suroyo, Indrati
author_sort Yulian, Erwin Danil
collection PubMed
description INTRODUCTION AND IMPORTANCE: Cancer of unknown primary site (CUP) is metastatic cancer without primary tumor found from comprehensive medical history, physical examination, and regular laboratory examination. Eighty percent of CUP include unfavorable groups with 3 to 6 months of median survival despite chemotherapy treatment. CASE PRESENTATION: A 52-year-old male was presented with a chief complaint of a recurrent lump in the neck and axilla. After comprehensive examinations over three years, the primary site of the metastatic tumor could not be found. Therefore, this patient was diagnosed with cancer of an unknown primary site. CLINICAL DISCUSSION: In patient with CUP, more precise therapy can only begin when the exact form of cancer is identified. However, the delay in diagnosis would worsen the patient's condition, as treatment measures cannot be implemented. CONCLUSION: Trimodal modalities including surgery, chemotherapy, and radiotherapy are suitable for CUP with squamous cell carcinoma proven in immunohistochemistry evaluation.
format Online
Article
Text
id pubmed-8961183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89611832022-03-30 Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report Yulian, Erwin Danil Hwei, Lie Rebecca Yen Tambun, Renaningtyas Siswoyo, Alvita Dewi Ham, Maria Fransisca Suroyo, Indrati Int J Surg Case Rep Case Report INTRODUCTION AND IMPORTANCE: Cancer of unknown primary site (CUP) is metastatic cancer without primary tumor found from comprehensive medical history, physical examination, and regular laboratory examination. Eighty percent of CUP include unfavorable groups with 3 to 6 months of median survival despite chemotherapy treatment. CASE PRESENTATION: A 52-year-old male was presented with a chief complaint of a recurrent lump in the neck and axilla. After comprehensive examinations over three years, the primary site of the metastatic tumor could not be found. Therefore, this patient was diagnosed with cancer of an unknown primary site. CLINICAL DISCUSSION: In patient with CUP, more precise therapy can only begin when the exact form of cancer is identified. However, the delay in diagnosis would worsen the patient's condition, as treatment measures cannot be implemented. CONCLUSION: Trimodal modalities including surgery, chemotherapy, and radiotherapy are suitable for CUP with squamous cell carcinoma proven in immunohistochemistry evaluation. Elsevier 2022-03-16 /pmc/articles/PMC8961183/ /pubmed/35339815 http://dx.doi.org/10.1016/j.ijscr.2022.106954 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Yulian, Erwin Danil
Hwei, Lie Rebecca Yen
Tambun, Renaningtyas
Siswoyo, Alvita Dewi
Ham, Maria Fransisca
Suroyo, Indrati
Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
title Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
title_full Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
title_fullStr Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
title_full_unstemmed Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
title_short Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
title_sort comprehensive evaluation on cancer of unknown primary site and how we managed it: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961183/
https://www.ncbi.nlm.nih.gov/pubmed/35339815
http://dx.doi.org/10.1016/j.ijscr.2022.106954
work_keys_str_mv AT yulianerwindanil comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport
AT hweilierebeccayen comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport
AT tambunrenaningtyas comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport
AT siswoyoalvitadewi comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport
AT hammariafransisca comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport
AT suroyoindrati comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport